You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKinsey
Johnson and Johnson
Baxter
Mallinckrodt

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 7,074,392

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,074,392
Title:Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
Abstract: A topical sustained release delivery system for delivery of antifungal agents to the finger or toenails achieving high penetration through the nails by combining the antifingal agent with a keratolytic agent and a humectant. The pharmaceutical sustained release topical preparation is provided in a varnish or spray form for treating the nail and surrounding tissues, where the active ingredient is an antifungal agent, a keratolytic agent, or preferably a combination of an antifuingal and a keratolytic agent. The composition may further comprise an antibacterial, an antiviral, an antipsoriatic agents, or combinations thereof.
Inventor(s): Friedman; Michael (Jerusalem, IL), Licht; Daniella (Givat Shmuel, IL), Cohen; Rachel (Hadera, IL), Yacobi; Avraham (Englewood, NJ)
Assignee: Taro Pharmaceutical Industries Limited (Haifa Bay, IL)
Application Number:09/534,960
Patent Claims:see list of patent claims

Details for Patent 7,074,392

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19   Start Trial Taro Pharmaceutical Industries Limited (Haifa Bay, IL) 2039-02-26 RX search
Medimmune SYNAGIS palivizumab VIAL 103770 002 1998-06-19   Start Trial Taro Pharmaceutical Industries Limited (Haifa Bay, IL) 2039-02-26 RX search
Aimmune Therapeutics PALFORZIA peanut KIT 125696 1 2020-01-31   Start Trial Taro Pharmaceutical Industries Limited (Haifa Bay, IL) 2039-02-26 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Mallinckrodt
Moodys
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.